Patent assignee · AT · COMPANY

AFFIRIS AG

24Patents
24Active
24Granted
49Portfolio score

Filing activity: Aug 8, 2008 → May 21, 2018 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8613931B2 Compounds for treating beta-amyloidoses Chemistry; Metallurgy 5 Active
US9724399B2 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Physics 3 Active
US11065273B2 Treatment and prevention of alzheimer's disease (AD) Human Necessities 1 Active
US9625459B2 Method for diagnosing alzheimer's disease (AD) Physics 1 Active
US10517935B2 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Physics 1 Active
US10053518B2 Substances and methods for the use in prevention and/or treatment in Huntington's disease Physics 1 Active
US10406197B2 Substances and methods for the use in prevention and/or treatment in Huntington's disease Physics 1 Active
US8618046B2 Treatment of atherosclerosis with cholesterol ester transport protein mimotopes Human Necessities 1 Active
US10646565B2 Treatment of alzheimer'S disease (AD) with an aluminum salt Human Necessities 1 Active
US10344062B2 Method of inhibiting C5a Chemistry; Metallurgy 0 Active
US8409581B2 Compounds for treating amyloidoses Chemistry; Metallurgy 0 Active
US9220762B2 PCSK9 peptide combination vaccine and method of use Chemistry; Metallurgy 0 Active
US10576131B2 IL-23-p19 vaccines Human Necessities 0 Active
US8828942B2 Means for treating synucleinopathies Chemistry; Metallurgy 0 Active
US9085636B2 CETP fragments Chemistry; Metallurgy 0 Active
US9457078B2 Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein Human Necessities 0 Active
US9029327B2 Vaccine Human Necessities 0 Active
US10933123B2 Peptide vaccines usable for hypercholesterolemia related diseases Human Necessities 0 Active
US9669079B2 PCSK9 peptide combination vaccine and method of use Chemistry; Metallurgy 0 Active
US9533030B2 Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo Human Necessities 0 Active
US10478454B2 Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide Human Necessities 0 Active
US9999659B2 Treatments using a peptide and/or vaccine Human Necessities 0 Active
US9964547B2 Method for detecting aSyn-specific antibodies in a biological sample Physics 0 Active
US10004791B2 Peptide vaccines against PCSK9 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.